000 | 01692nam a22002417a 4500 | ||
---|---|---|---|
999 |
_c7841 _d7841 |
||
001 | 4672 | ||
003 | PILC | ||
005 | 20240720152601.0 | ||
008 | 160505b2013 xxu||||| |||| 00| 0 eng d | ||
040 | _cFEU-NRMF MEDICAL LIBRARY | ||
041 | _aEnglish | ||
050 | _aRES OB 2013 0005 | ||
100 | _aAlensuela, Anabelle, M.D. | ||
245 | _aTwo Wrongs Can Never Do One Right: Polycystic Ovarian Syndrome with Concomittant Mullerian Anomaly : A Case Report | ||
264 | 0 | _c2013 | |
336 | _aText | ||
337 | _aUnmediated | ||
338 | _aVolume | ||
502 |
_bMEDICINE _gResearch project |
||
520 | _aThis was a case of an 18-year old nulligravida, diagnosed with Polycystic Ovarian Syndrome (PCOS) presenting with primary amenorrhea and with concomitant Mullerian Duct Anomaly Type I (vaginal agenesis). Although PCOS more commonly present with Secondary Amenorrhea, the reported percentage of Primary Amenorrhea as an initial feature in PCOS among small cohorts varied between 1.4% and 14%. Mullerian anomalies, on the other hand were reported in up to 3.2% of all women. One study, which correlated the two disease entities, concluded that an embryologic defect in the ovaries might have given rise to the non-development of the Mullerian duct thereby producing various anatomic defects of the uterus, cervix and upper part of the vagina. When presented with such a case, efforts should be made to diagnose and treat the PCOS first to minimize the development of symptoms and prevent the onset of cardiovascular and metabolic disturbances. The creation of a neovagina to address the vaginal agenesis, on the other hand, can be done later on. | ||
887 | _aRES RC RC00014 | ||
942 |
_2lcc _cRE |